Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000727499 | SCV000242955 | likely benign | not provided | 2021-03-10 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727499 | SCV000709152 | uncertain significance | not provided | 2017-06-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001080737 | SCV001009555 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2025-01-05 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000727499 | SCV001713549 | uncertain significance | not provided | 2020-05-01 | criteria provided, single submitter | clinical testing | |
Center for Genomics, |
RCV002054230 | SCV002495960 | uncertain significance | Developmental and epileptic encephalopathy, 3 | 2021-05-16 | criteria provided, single submitter | clinical testing | SLC25A22 NM_024698.5 exon 3 p.Thr47Met (c.140C>T): This variant has not been reported in the literature but is present in 0.2% (80/41470) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/11-794782-G-A?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:207161). Evolutionary conservation suggests that this variant may not impact the protein; computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Ambry Genetics | RCV002390499 | SCV002699240 | uncertain significance | Inborn genetic diseases | 2020-09-30 | criteria provided, single submitter | clinical testing | The p.T47M variant (also known as c.140C>T), located in coding exon 2 of the SLC25A22 gene, results from a C to T substitution at nucleotide position 140. The threonine at codon 47 is replaced by methionine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Athena Diagnostics | RCV000727499 | SCV002770529 | uncertain significance | not provided | 2021-06-15 | criteria provided, single submitter | clinical testing |